a.kirchner
TL2 Moderator · Kristiansand
Contributes reviews on supplier material. Based in Kristiansand.
Joined 11 June 2025 · last posted 2d
80 posts, newest first. Showing up to 150.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #92 · Practice › Interactions · 26 Jul 2026 · 0 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
What I would want from a home test that does not exist yet Replied, post #48 · Analytics › Home & field testing · 25 Jul 2026 · 26 likes Picking up post #45: that is the part I would want checked first. What physical quantity does the device measure? A colorimetric or lateral-flow method typically…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #103 · Evidence › Journal club · 23 Jul 2026 · 26 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Mobile reading experience on long topics Replied, post #15 · Meta › Site feedback · 21 Jul 2026 · 26 likes Coming back to post #13, because the follow-up matters more than the original answer. Display issues: broken layouts, images not loading, text overlapping — report with…
-
Aggregate verification data across the directory, with caveats Replied, post #56 · Sourcing › Independent verification · 19 Jul 2026 · 23 likes post #55 answers the question as asked. The question underneath it is different. Interpreting a result: a purity figure is one measurement on one vial on one day.…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #63 · Outcomes › Body composition · 18 Jul 2026 · 11 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Here for the analytics and not much else Replied, post #44 · Lounge › Introductions · 16 Jul 2026 · 21 likes Lurking first: if you want to introduce yourself after lurking a bit, that is fine. You do not have to introduce yourself before your first technical post either.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #69 · Nutrition & Training › Protein & intake · 16 Jul 2026 · 0 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #49 · Pharmacology › Pharmacokinetics · 13 Jul 2026 · 13 likes I read post #47 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #77 · Sourcing › Independent verification · 9 Jul 2026 · 13 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #17 · Practice › Dosing & titration · 8 Jul 2026 · 12 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #49 · Access › Insurance & coverage · 1 Jul 2026 · 0 likes Worth separating two things that post #45 runs together. Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #67 · Outcomes › Progress reports · 29 Jun 2026 · 11 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
-
Run-in periods and the population they select Replied, post #143 · Evidence › Trials · 25 Jun 2026 · 6 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Journal club: what we got wrong in an earlier session Replied, post #20 · Evidence › Journal club · 22 Jun 2026 · 18 likes post #19 answers the question as asked. The question underneath it is different. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #80 · Safety › Contraindications · 20 Jun 2026 · 0 likes Severe renal impairment (eGFR
-
Transporting a vial for a weekend away — a second dataset Replied, post #84 · Practice › Storage & stability · 16 Jun 2026 · 10 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #42 · Practice › Administration · 15 Jun 2026 · 22 likes Worth separating two things that post #38 runs together. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #24 · Compounds › Oral incretins · 2 Jun 2026 · 0 likes This follows post #21 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #8 · Practice › Storage & stability · 29 May 2026 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A site rotation scheme that is easy enough to actually follow Replied, post #55 · Practice › Administration · 4 May 2026 · 1 like Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Personal import allowances, compared — a second dataset Replied, post #116 · Access › International · 4 May 2026 · 2 likes post #115 is right about the mechanism and I think understates the practical bit. Compounding in different countries: some countries allow pharmacy compounding under…
-
Request: show the solution author in the topic list — what changed since Replied, post #61 · Meta › Feature requests · 3 May 2026 · 0 likes Requests for platform and documentation features, with the reasoning that justifies them. If you think the site would be better with a feature, suggest it with enough…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #59 · Data & Tools › Datasets · 1 May 2026 · 0 likes How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset.
-
A 10 mg vial reconstituted three different ways, compared Replied, post #17 · Practice › Reconstitution · 30 Apr 2026 · 15 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The anatomy of a question that gets answered within an hour Replied, post #23 · Start Here › How to Ask · 20 Apr 2026 · 10 likes On post #19 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #74 · Clinical › Comorbidities · 19 Apr 2026 · 0 likes This follows post #71 rather than contradicting it. Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision…
-
Spike-and-recover accuracy for a peptide assay Replied, post #82 · Analytics › Method validation · 9 Apr 2026 · 0 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Follow-up: State-level differences that actually matter Replied, post #20 · Regional › North America · 4 Apr 2026 · 11 likes Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream…
-
Why the timeline is on the right and not the left — what changed since Replied, post #5 · Meta › Site feedback · 10 Mar 2026 · 1 like Navigation problems: if you cannot find something you expected to exist, or the path to it is unclear, report it. Site architecture affects usability.
-
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #12 · Compounds › Semaglutide · 7 Mar 2026 · 17 likes Coming back to post #10, because the follow-up matters more than the original answer. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #57 · Clinical › Bloodwork · 28 Feb 2026 · 1 like post #56 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #32 · Clinical › Special populations · 22 Jan 2026 · 5 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
Substitution between formats during a shortage Replied, post #123 · Access › Shortages · 25 Dec 2025 · 14 likes I read post #121 twice before replying, because I had assumed the opposite. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and…
-
Follow-up: Sodium, potassium and magnesium when intake drops Replied, post #13 · Nutrition & Training › Hydration & electrolytes · 22 Dec 2025 · 0 likes Coming back to post #11, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #39 · Compounds › Semaglutide · 29 Nov 2025 · 5 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Documentation that materially improves an appeal's chances Replied, post #81 · Access › Insurance & coverage · 28 Nov 2025 · 11 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
-
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #19 · Analytics › Method validation · 25 Nov 2025 · 0 likes This follows post #16 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Availability by country, dated, with primary sources — one year on Started this topic · Access › International · 18 Nov 2025 · 0 likes Availability by country, dated, with primary sources — one year on — setting out what I have, and where I think it stops being reliable. Documenting an access outcome,…
-
Cross-border purchase rules within the EU Replied, post #39 · Regional › European Union · 15 Nov 2025 · 0 likes I read post #37 twice before replying, because I had assumed the opposite. EMA is the regulator with national implementation. Licensed incretin analogues are…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #56 · Compounds › Tirzepatide · 13 Nov 2025 · 22 likes On post #52 — agreed on the reasoning, with one qualification. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect…
-
Publishing an inconvenient result: a case study — the long version Replied, post #30 · Sourcing › Independent verification · 7 Nov 2025 · 8 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #56 · Safety › Adverse events · 25 Oct 2025 · 0 likes Allergic reactions: true allergy (anaphylaxis, severe rash) is rare with these peptide compounds but possible. Distinguishing true allergy from GI intolerance matters.
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #49 · Compounds › Tirzepatide · 19 Oct 2025 · 32 likes Picking up post #46: that is the part I would want checked first. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #5 · Pharmacology › Pharmacokinetics · 17 Oct 2025 · 3 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #63 · Practice › Dosing & titration · 14 Oct 2025 · 3 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Cost per delivered dose, which is the number that matters Replied, post #7 · Access › Pricing · 11 Sep 2025 · 31 likes List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
-
Revisiting: German, French and Dutch differences, compared Replied, post #68 · Regional › European Union · 5 Sep 2025 · 2 likes Spain: AEMPS is the regulator. Public reimbursement for weight management has been limited with regional variation in specialist pathways. Private prescription is common.
-
High-resolution MS on aggregates and what it can see Replied, post #58 · Analytics › Mass spectrometry · 2 Sep 2025 · 21 likes post #57 is right about the mechanism and I think understates the practical bit. Mass accuracy is expressed in parts per million. It is the difference between observed…
-
Counter-ion content and its effect on measured mass Replied, post #109 · Analytics › Mass spectrometry · 1 Aug 2025 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Canadian access and provincial variation — one year on Replied, post #40 · Regional › North America · 28 Jul 2025 · 0 likes Coming back to post #38, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #25 · Analytics › COA interpretation · 22 Jul 2025 · 0 likes Picking up post #22: that is the part I would want checked first. What fields matter on a certificate: lot number matching the vial, test date, the analytical method…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #158 · Practice › Reconstitution · 8 Jul 2025 · 8 likes I read post #156 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Insulin combinations and hypoglycaemia risk Replied, post #23 · Practice › Interactions · 27 Jun 2025 · 0 likes This follows post #20 rather than contradicting it. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already…
-
Reading a supplier's product description as a marketing document Replied, post #37 · Compounds › Other compounds · 25 Jun 2025 · 0 likes On post #33 — agreed on the reasoning, with one qualification. This subcategory exists because some people will research compounds outside the main groups discussed…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #56 · Outcomes › Progress reports · 24 May 2025 · 0 likes Picking up post #53: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Telehealth prescribing models in the US Replied, post #99 · Regional › North America · 15 May 2025 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #20 · Evidence › Trials · 2 May 2025 · 20 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reading a trial's population section before its results — does this still hold? Replied, post #45 · Evidence › Trials · 27 Apr 2025 · 5 likes Coming back to post #43, because the follow-up matters more than the original answer. Population narrowness: most trials in this class enrolled fairly specific groups.…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #105 · Compounds › Cagrilintide & amylin analogues · 27 Apr 2025 · 0 likes Picking up post #102: that is the part I would want checked first. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms.…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #43 · Practice › Reconstitution · 26 Apr 2025 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Asking about a compound your prescriber has not heard of Replied, post #15 · Clinical › Prescriber conversations · 12 Apr 2025 · 22 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #3 · Evidence › Trials · 28 Mar 2025 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Retatrutide dose escalation in the published trials Replied, post #54 · Compounds › Retatrutide · 27 Mar 2025 · 16 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #10 · Devices › Cold chain · 21 Mar 2025 · 30 likes Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised powder. Refrigerate prepared solutions immediately after preparation. Most…
-
Consistent declarations and why they matter more than clever ones Replied, post #137 · Sourcing › Logistics · 6 Mar 2025 · 0 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #38 · Practice › Reconstitution · 28 Feb 2025 · 5 likes On post #34 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #106 · Access › Insurance & coverage · 6 Jan 2025 · 25 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #14 · Compounds › Semaglutide · 1 Jan 2025 · 26 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Second pass at: Albumin binding and how it produces a long half-life Replied, post #7 · Pharmacology › Pharmacokinetics · 28 Nov 2024 · 0 likes This follows post #4 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #16 · Wellbeing › Mental health · 11 Nov 2024 · 3 likes post #15 answers the question as asked. The question underneath it is different. Sleep and mental health: these compounds can affect sleep for some people. Sleep…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #32 · Meta › Wiki maintenance · 10 Nov 2024 · 22 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #7 · Compounds › Tirzepatide · 2 Nov 2024 · 15 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Progressive overload when the scale is falling — one year on Replied, post #126 · Nutrition & Training › Resistance training · 5 Oct 2024 · 20 likes Coming back to post #124, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #52 · Practice › Administration · 24 Sep 2024 · 0 likes On post #48 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Gallbladder disease risk with rapid weight loss Replied, post #7 · Clinical › Comorbidities · 7 Sep 2024 · 0 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #48 · Clinical › Prescriber conversations · 31 Aug 2024 · 0 likes I read post #46 twice before replying, because I had assumed the opposite. How to ask for what you need: rather than "should I take this", frame it as "I understand the…
-
Correlation in a self-tracked dataset: what it can support Replied, post #125 · Research Methods › Statistics · 25 Aug 2024 · 30 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #14 · Nutrition & Training › Hydration & electrolytes · 27 Jul 2024 · 12 likes I read post #12 twice before replying, because I had assumed the opposite. The very ordinary causes of week-two malaise: inadequate hydration, low sodium intake,…
-
Journal club: FLOW and the renal composite, component by component Replied, post #57 · Evidence › Journal club · 14 Jul 2024 · 5 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…